Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adherence-blocking vaccine for amebiasis.

William A Petri1, Omer Chaudhry, R Haque

  • 1Division of Infectious Diseases and International Health, University of Virginia Health System, Charlottesville, Virginia 22908-1340, USA. wap3g@virginia.edu

Archives of Medical Research
|December 29, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhanced detection of sepsis pathogens in hospitalized febrile neutropenia patients using blood culture broths with TaqMan array card.

Research square·2026
Same author

Genomic epidemiology of a 2023-2024 Oropouche virus disease outbreak in Iquitos, Peru: descriptive analysis of a case control study for acute febrile illness.

Lancet regional health. Americas·2026
Same author

Acute febrile illness surveillance using TaqMan Array Cards in two urban health facilities, Monrovia, Liberia, December 2018-March 2020.

PLoS neglected tropical diseases·2026
Same author

Robust Performance of Culture, qPCR, and Genomic Approaches for Shigella Serotyping in a Pediatric Surveillance Cohort.

medRxiv : the preprint server for health sciences·2026
Same author

Natural history parameters for enteric pathogens to inform modeling studies of diarrhea among children in low-resource settings: results from the MAL-ED longitudinal birth cohort.

BMC infectious diseases·2025
Same author

Enteric pathogen carriage in early childhood is associated with elevated CRP, lower IGF-1 and linear growth deficits: the ELICIT study in rural Tanzania.

BMJ global health·2025
Same journal

Early-Life Lipid Exposure Induces Lasting Skeletal Muscle Remodeling Via Fetal Programming in Male Wistar Rats.

Archives of medical research·2026
Same journal

Peripubertal Physical Activity in Male Wistar Rats Helps to Prove the Concept of Developmental Origins of Health and Disease.

Archives of medical research·2026
Same journal

Associations between Red Blood Cell Transfusions and Health-Related Outcomes in Older Adults with Hip Fractures: A Systematic Review with Meta-Analysis.

Archives of medical research·2026
Same journal

Association of MBL2 Polymorphisms with HAM/TSP in HTLV-1 Infection: A Case-Control Study Approach.

Archives of medical research·2026
Same journal

Financial Costs of Tobacco-Attributable Temporary Sick Leave in Social Security Systems: The Case of Mexico, 2010-2022.

Archives of medical research·2026
Same journal

Access to Medicines for Rare Diseases in Brazil.

Archives of medical research·2026
See all related articles

The Gal/GalNAc lectin

Area of Science:

  • Parasitology and immunology, focusing on vaccine development for infectious diseases.

Background:

  • Amebiasis is a significant global health concern caused by Entamoeba histolytica.
  • The Gal/GalNAc lectin mediates parasite adherence and is a target for immune responses.
  • Partial human immunity correlates with mucosal IgA against this lectin.

Purpose of the Study:

  • To evaluate the LecA domain of the Gal/GalNAc lectin as a vaccine antigen for amebiasis.
  • To identify research needs for developing a cGMP-producible and immunogenic LecA-based vaccine.

Main Methods:

  • Investigating the role of the Gal/GalNAc lectin in amebiasis pathogenesis.
  • Assessing the LecA domain's potential as a vaccine candidate in preclinical models.
  • Exploring the use of adjuvants like alum, MF59, and QS-21 to enhance immunogenicity.

Related Experiment Videos

Main Results:

  • The LecA domain contains neutralizing antibody epitopes and the lectin's active site.
  • LecA has demonstrated efficacy as a vaccine antigen in murine models of amebic colitis and liver abscess.

Conclusions:

  • The LecA domain is a promising candidate antigen for an amebiasis vaccine.
  • Further research is needed for cGMP production and immunogenicity optimization of LecA for human trials.